Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

QNCXQNCX

Showing 7 of 20 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in QUINCE THERAPEUTICS INC

No. Renaissance Technologies exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 538,100 shares worth $1.8M. Renaissance Technologies first reported QNCX in Q1 2020 and held it in 18 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$405,624

Total Shares Change

-522,576

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$20.20
0
2025-Q4
Increased
538,100
+14.8%
$1.8M0.0%$670.00
29
2025-Q3
Increased
468,598
+23.4%
$763,8150.0%$326.00
30
2025-Q2
Decreased
379,800
-24.0%
$626,6700.0%$330.00
0
2025-Q1
Decreased
499,907
-4.4%
$664,8760.0%$266.00
0
2024-Q4
Increased
523,050
+0.1%
$978,1040.0%$374.00
25
2024-Q3
Increased
522,576
+8.0%
$405,6240.0%$155.20
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used